Lung protection strategy as an effective treatment in acute respiratory distress syndrome

Acute respiratory distress syndrome is a challenging entity for the intensivist. The pathological hallmark of the acute phase is diffuse alveolar damage, which is present in approximately half of living patients with acute respiratory distress syndrome. It is clear that respiratory support for acute respiratory distress syndrome has gradually been improving over recent decades. However, it is a...

High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. beneficial effects of the 'Open Lung Approach' with low distending pressures in acute respiratory distress syndrome. Effect of protective-ventilation strategy on mortality in the acute respiratory distress syndrome. 6 The Acute Respiratory Distress Syndrome Network. V...

Background: Chest radiography is one of the most usual diagnostic tools for respiratory distress. Objective: The purpose of this study is to assess the specificity, sensitivity and clinical value of chest radiography of neonates with respiratory distress.Patients and Methods: A descriptive- analytical study was conducted on 102 neonates that were in neonatal intensive care unit of Imam Reza and...

OBJECTIVE The aim of this study was to determine the effects of fenofibrate (160 mg/day) on fasting and postprandial lipoproteins, oxidized fatty acids, and inflammatory mediators in subjects with hypertriglyceridemia and the metabolic syndrome. RESEARCH DESIGN AND METHODS Fifty-nine subjects with fasting hypertriglyceridemia (> or = 1.7 and < 6.9 mmol/l) and two or more of the Adult Treatmen...

Neonatal respiratory distress syndrome [4], previously called hyaline membrane disease, is a respiratory disease affecting premature newborns. Neonatal respiratory distress syndrome [4] involves shallow breathing, pauses between breaths that last a few seconds, or apnea, and a bluish tinge to the infant?s skin. The syndrome occurs when microscopic sacs called alveoli in infant lungs do not prod...

Neonatal respiratory distress syndrome [4], previously called hyaline membrane disease, is a respiratory disease affecting premature newborns. Neonatal respiratory distress syndrome [4] involves shallow breathing, pauses between breaths that last a few seconds, or apnea, and a bluish tinge to the infant?s skin. The syndrome occurs when microscopic sacs called alveoli in infant lungs do not prod...

Neonatal respiratory distress syndrome [4], previously called hyaline membrane disease, is a respiratory disease affecting premature newborns. Neonatal respiratory distress syndrome [4] involves shallow breathing, pauses between breaths that last a few seconds, or apnea, and a bluish tinge to the infant?s skin. The syndrome occurs when microscopic sacs called alveoli in infant lungs do not prod...

Neonatal respiratory distress syndrome [4], previously called hyaline membrane disease, is a respiratory disease affecting premature newborns. Neonatal respiratory distress syndrome [4] involves shallow breathing, pauses between breaths that last a few seconds, or apnea, and a bluish tinge to the infant?s skin. The syndrome occurs when microscopic sacs called alveoli in infant lungs do not prod...

Neonatal respiratory distress syndrome [4], previously called hyaline membrane disease, is a respiratory disease affecting premature newborns. Neonatal respiratory distress syndrome [4] involves shallow breathing, pauses between breaths that last a few seconds, or apnea, and a bluish tinge to the infant?s skin. The syndrome occurs when microscopic sacs called alveoli in infant lungs do not prod...